# Ally Financial Inc.: overview

ALLY · NYSE · CIK 40729 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ally.md) · [Financials](/companies/ally/financials.md) · [Filings](/companies/ally/filings.md) · [Insiders](/companies/ally/insiders.md)

Latest reported revenue: [$310.0m](/filings/0000040729-26-000017.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 23, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000040729-26-000017).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [319](/filings/0000040729-25-000025.md) | [311 d](/filings/0000040729-26-000005.md) | [323](/filings/0000040729-26-000009.md) | [312](/filings/0000040729-26-000017.md) | [308](/filings/0000040729-25-000025.md) | [301 d](/filings/0000040729-26-000005.md) | [307](/filings/0000040729-26-000009.md) | [310](/filings/0000040729-26-000017.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [62.1%](/filings/0000040729-25-000025.md) | [34.7% d](/filings/0000040729-25-000006.md) | [(69.7%)](/filings/0000040729-26-000009.md) | [112.8%](/filings/0000040729-26-000017.md) | [129.2%](/filings/0000040729-25-000025.md) | [108.6% d](/filings/0000040729-26-000005.md) | [103.9%](/filings/0000040729-26-000009.md) | [132.3%](/filings/0000040729-26-000017.md) |
| Diluted EPS | $ per share | [0.55](/filings/0000040729-25-000025.md) | [0.26](/filings/0000040729-25-000006.md) | [(0.82)](/filings/0000040729-26-000009.md) | [1.04](/filings/0000040729-26-000017.md) | [1.18](/filings/0000040729-25-000025.md) | not reported | [0.93](/filings/0000040729-26-000009.md) | [1.18](/filings/0000040729-26-000017.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [852](/filings/0000040729-24-000004.md) | [908](/filings/0000040729-25-000006.md) | [968](/filings/0000040729-26-000005.md) | [1,198](/filings/0000040729-26-000005.md) | [1,244](/filings/0000040729-26-000005.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [359.2%](/filings/0000040729-24-000004.md) | [188.8%](/filings/0000040729-25-000006.md) | [98.9%](/filings/0000040729-26-000005.md) | [55.8%](/filings/0000040729-26-000005.md) | [68.5%](/filings/0000040729-26-000005.md) |
| Diluted EPS | $ per share | [8.22](/filings/0000040729-24-000004.md) | [5.03](/filings/0000040729-25-000006.md) | [2.77](/filings/0000040729-26-000005.md) | [1.80](/filings/0000040729-26-000005.md) | [2.37](/filings/0000040729-26-000005.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ally/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-21 | [Patterson Kathleen L.](/insiders/2047749.md) | Chief HR & Corp Citizenship, Officer | Sale (S) | 12,831 | $38.6473 | $495.9k | [Form 4](/filings/0002047749-26-000006.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.32bn | 28,632,394 |  | Added +98,161 |
| [Berkshire Hathaway Inc](/funds/1067983.md) | 2026-06-30 | $1.24bn | 27,000,000 |  | Reduced −2,000,000 |
| [HARRIS ASSOCIATES L P](/funds/813917.md) | 2026-06-30 | $1.20bn | 26,105,434 |  | Reduced −304,851 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $647.8m | 14,098,964 |  | Added +749,885 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $574.1m | 12,493,411 |  | Added +19,564 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $473.7m | 10,308,012 |  | Reduced −1,050,896 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $428.8m | 9,331,607 |  | Added +313,027 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $408.3m | 8,885,383 |  | Added +202,405 |
| [Sessa Capital IM, L.P.](/funds/1595849.md) | 2026-06-30 | $390.0m | 8,488,098 |  | Unchanged |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $315.4m | 6,863,117 |  | Added +79,170 |

## Recent filings

[All 3,400 filings](/companies/ally/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 11:20 ET | [8-K](/filings/0001193125-26-425698.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-425698 |
| 2026-10-07 | 20:21 ET | [8-K](/filings/0000040729-26-000021.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000040729-26-000021 |
| 2026-09-16 | 20:06 ET | [8-K](/filings/0001193125-26-393065.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-393065 |
| 2026-07-23 | 20:25 ET | [10-Q](/filings/0000040729-26-000017.md) | Quarterly report, period 2026-06-30 | 0000040729-26-000017 |
| 2026-07-21 | 11:20 ET | [8-K](/filings/0001193125-26-309539.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-309539 |
| 2026-05-20 | 21:48 ET | [8-K](/filings/0001193125-26-231197.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-231197 |
| 2026-05-08 | 20:12 ET | [8-K](/filings/0000040729-26-000011.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000040729-26-000011 |
| 2026-05-05 | 21:21 ET | [10-Q](/filings/0000040729-26-000009.md) | Quarterly report, period 2026-03-31 | 0000040729-26-000009 |
| 2026-05-01 | 20:24 ET | [8-K](/filings/0001193125-26-201520.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-201520 |
| 2026-04-27 | 12:59 ET | [8-K](/filings/0001193125-26-179290.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-179290 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000040729-26-000005.md), filed Feb 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 40729
- Tickers: ALLY
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.